Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.

Dik A, Landmeyer N, Gmahl N, Bierhansl L, Dadarwal R, Kosfeld A, Pawlowski M, Brix T, Gross CC, Meyer Zu Hörste G, Wiendl H, Bischof A, Elger C, Meuth SG, Kovac S

Open source

DOI
10.1016/j.isci.2026.116689
Published
2026 Aug 21
Container
iScience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2026.116689,
  title = {Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.},
  author = {Dik A and Landmeyer N and Gmahl N and Bierhansl L and Dadarwal R and Kosfeld A and Pawlowski M and Brix T and Gross CC and Meyer Zu Hörste G and Wiendl H and Bischof A and Elger C and Meuth SG and Kovac S},
  year = {2026},
  journal = {iScience},
  doi = {10.1016/j.isci.2026.116689},
  url = {https://doi.org/10.1016/j.isci.2026.116689}
}

RIS

TY  - JOUR
TI  - Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.
AU  - Dik A
AU  - Landmeyer N
AU  - Gmahl N
AU  - Bierhansl L
AU  - Dadarwal R
AU  - Kosfeld A
AU  - Pawlowski M
AU  - Brix T
AU  - Gross CC
AU  - Meyer Zu Hörste G
AU  - Wiendl H
AU  - Bischof A
AU  - Elger C
AU  - Meuth SG
AU  - Kovac S
PY  - 2026
JO  - iScience
DO  - 10.1016/j.isci.2026.116689
UR  - https://doi.org/10.1016/j.isci.2026.116689
ER  - 

APA

A, D., N, L., N, G., L, B., R, D., A, K., M, P., T, B., CC, G., G, M. Z. H., H, W., A, B., C, E., SG, M., & S, K. (2026). Immune context and treatment timing associated with seizure freedom after rituximab in autoimmune limbic encephalitis.. iScience. https://doi.org/10.1016/j.isci.2026.116689

Source records